large_news-and-events.png

news-and-events.png

Joseph Magero, member of the Oral Nicotine Commission, wrote about new research published in Kenya in December 2021. A review by a team from the University of Nairobi reported Kenyans are using a variety of oral stimulants and each carries its own varying degree of risk. The found users are more likely to consume the riskier products such as chewing tobacco, areca and khat. 

They concluded: we should be making much greater effort to encourage these people towards available tobacco-free products that carry a lesser risk, such as nicotine replacement therapies (NRT) and nicotine pouches.

Unknown-1 1.png

Tobacco: Calculated risks can save many lives in Kenya

Globally, [almost 400,000 people](https://www.nature.com/articles/s41432-022-0243-1#:~:text=Data%20from%20the%20Global%20Cancer,and%20North%20America%20(27%2C469).) are diagnosed with oral cancer every year. [Smokeless-tobacco](https://oralnicotine.com/oral-nicotine/what-is-it) use is a major risk factor for oral cancer, but what was less clear is the association between [Swedish snus](https://en.wikipedia.org/wiki/Snus) use and oral cancer.

A team at the [Karolinska Institutet in Sweden](https://ki.se/en) recently released an [extensive review](https://pubmed.ncbi.nlm.nih.gov/32466721/) on snus, based on nine major cohort studies. Using pooled individual data from the [Swedish Collaboration on Health Effects of Snus Use](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825961/#:~:text=Snus%20use%20was%20associated%20with,an%20association%20with%20cancer%20mortality.), the team used linkage to health registers to follow up on 418,369 male participants for oral cancer incidence.

The findings show that, compared to never-snus use, ever-snus use is not associated with oral cancer. Furthermore, among never smokers, snus use was not associated with oral cancer. The conclusion? There appears to be no link between Swedish snus use and the development of oral cancer in men.

To read more about the benefits of oral nicotine, [click here](https://oralnicotine.com/oral-nicotine/benefits).

xsmall_Unknown-1 2.png

Unknown-1 2.png

Study finds no association between snus use and oral cancer

The Africa Tobacco Harm Reduction Forum (ATHRF) is an important conference on the public health calendar. Convened by Campaign for Safer Alternatives (CASA), the forum is aimed at providing a platform to engage, challenge, and exchange ideas, where pivotal issues on ending smoking in Africa are discussed and where delegates can learn from the experience, opinions, and perspectives of sector leaders and their peers. 

The second edition of the Forum will be held as a hybrid conference, combining face-to-face and virtual components, on Monday 14th February 2022 at the Ole Sereni Hotel, Nairobi Kenya.

xsmall_athrf.png

athrf.png

Africa Tobacco Harm Reduction Forum, Nairobi Monday 14 February 2022

News & Events

Explore research on oral nicotine, policy, and public health. The Oral Nicotine Commission analyses evidence to inform science, policy, and consumer understanding.